Research programme: trophic factor biotherapeutics - Mesoblast

Drug Profile

Research programme: trophic factor biotherapeutics - Mesoblast

Alternative Names: Cytokine biotherapeutics - Mesoblast; SDF-1 - Mesoblast; Stromal derived factor-1 - Mesoblast

Latest Information Update: 05 Feb 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Mesoblast
  • Class CXC chemokines; Peptides; Small molecules
  • Mechanism of Action Angiogenesis inducing agents; CXCR4 receptor agonists; Leukocyte stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Cardiovascular disorders

Most Recent Events

  • 29 Jan 2014 Preclinical trials in Cardiovascular disorders in Australia (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top